glp-1 compound podcast Poll STUNS THE INTERNET! by On The Pen GLP-1 News Hims & Hers, and the

SURMOUNT-1 Trial (Tirzepatide, N=2,539) Tirzepatide, a dual GIP and GLP-1 receptor agonist, produced a similar GI side-effect profile

Lewy bodies, once thought to be mere markers, are now considered active participants in disease propagation due to their interaction with endolysosomal and mitochondrial pathways (Dorsey et al., 2024

The Bridge program extends coverage to obesity management as a standalone indication

Small-molecule drugs are organic compounds that have a low molecular weight and could target regulatory proteins as a method for probing biologically relevant molecular pathways such as ferroptosis [117]